SURVYR

TNDM

Tandem Diabetes Care, Inc.
$19.22
+$0.32 (1.69%)Oct 27 close
Health CareS&P 600 CompareTechnicals
1M3M6M1Y2Y
-18%+11%+40%+69%+98%Oct 2025Oct 2026Apr 202652w high $29.6552w low $12.26
TNDMSPY
Wall St. Highest PT $50.00 (+160.1%) Wall St. Avg PT $27.76 (+44.4%)
$13$23$33$43$54POC $17Hi $50Avg $28
Underwater Drawdown %Max DD -54.6%Current -32.0%
0.0%-54.6%
Relative Strength vs SPY+15.1% vs SPYOutperforming
+103%0%-103%
1W
+$2.70 (16.34%)
1M
+$3.50 (22.26%)
3M
+$1.46 (8.22%)
6M
+$0.59 (3.17%)
YTD
−$2.76 (12.56%)
1Y
+$4.28 (28.65%)

Chart

Loading live chart…

Ratings & dials

1m · 5m · 15m · 1h · 4h · 1D

Analyst & Morningstar ratings

Consensus · Targets · Morningstar
Wall Street analyst consensus
SellHoldStrong Buy
Buy
21 analysts · mean score 2.04
1 = Strong Buy · 5 = Sell
Wall Street consensus
Analyst price targets
Current price$19.22
Average target$27.76
+$8.54 (+44.4%) upsideaverage target vs current price
CurrentAverageMedian
Low$18.00
Median$27.76
High$50.00
12-month Wall Street target range
Recent analyst rating changes · 30
Initiated
2026-10-07 · Barclays started covering TNDM at Equal-Weight
Reiterated
2026-09-30 · Citigroup reiterated Neutral on TNDM
Reiterated
2026-09-24 · Truist Securities reiterated Buy on TNDM
Initiated
2026-08-21 · William Blair started covering TNDM at Outperform
Reiterated
2026-08-07 · Citigroup reiterated Neutral on TNDM
Reiterated
2026-08-07 · RBC Capital reiterated Outperform on TNDM
All analyst rating changes ›

Third-party ratings, not SURVYR.'s views.

Key stats & company

Market value$1.2B
P/E (next 12 months, estimated)109.7
52-week range$12.26 – $29.65
Revenue growth (latest quarter vs a year ago)+5.8%
Dividend yieldNo dividend
Analyst consensusBuy (21)
Average analyst price target$27.76 (+44%)

What they do

Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. It's flagship products are the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. The company also sells single-use products, including cartridges for storing and delivering insulin.

Healthcare · Medical Devices
Valuation and fundamentals

Valuation & fundamentals

Loading the valuation from SEC filings…

For information only · Important disclosures

Grades vs sector

Momentum
47th percentile in sector
C
12-1 return: +16.5%
Percentile within its GICS sector across the S&P 1500.
Growth
35th percentile in sector
C-
Revenue growth (YoY): +5.8%
Percentile within its GICS sector across the S&P 1500.
Value
3rd percentile in sector
F
Forward E/P: 1.0% · EBITDA/EV: –
Percentile within its GICS sector across the S&P 1500.
Profitability
9th percentile in sector
D-
Profit margin: -6.1% · Return on equity: -48.0%
Percentile within its GICS sector across the S&P 1500.
Revisions
Not enough data yet
–
EPS estimate change, 30 days (current FY): –
30-day change in analysts' current-year EPS estimate; graded across covered stocks.

Systematic Models

Not held by any of our 7 live models right now.

Quality Growth
Outside this model's universe or screens
 Momentum Top 15
Outside this model's universe or screens
 Momentum Blend
Not in the current book
 New Highs Growth
Outside this model's universe or screens
 SURVYR. Barbell Momentum & T-Bill Shield
Outside this model's universe or screens
 SURVYR. Physical AI Grid & Power
Outside this model's universe or screens
 SURVYR. Long Book
Not in the current book

Earnings & events

TNDM earningsNext report in 8 days
Next report · quarter Sep 2026
Thu Nov 5, 2026After the close
EPS consensus-$0.24 range -$0.36–-$0.16
Revenue consensus$265.8M 22 analysts
Last 4 quarters · EPS vs estimate
Aug 6, 2026-$0.31est -$0.32+2.8%Above estimates
May 7, 2026-$0.30est -$0.44+32.1%Above estimates
Feb 19, 2026-$0.01est -$0.09+88.9%Above estimates
Nov 6, 2025-$0.31est -$0.34+8.9%Above estimates

In line = within 1% of the estimate.

Source: Yahoo Finance · report time: Nasdaq earnings calendar · refreshed 2026-10-23 23:42:59 ET
24-1125-0225-0425-0825-1126-0226-0526-08-0.670.00
EstimateActual (beat)Actual (miss)

Quarterly revenue

QuarterRevenueYoY
2026-06-30$254.6M+5.8%
2026-03-31$247.2M–
2025-12-31$290.4M–
2025-09-30$249.3M–
2025-06-30$240.7M–

News & catalysts

More news
Is it the Right Time to Hold TNDM Stock in Your Portfolio?
Zacks · Oct 09
Flutter upgraded, AppFolio downgraded: Wall Street's top analyst calls
The Fly · Oct 07
Tandem Diabetes Care to Announce Third Quarter 2026 Financial Results on November 5, 2026
Business Wire · Oct 01
Tandem Diabetes Care (TNDM) Is Up 7.2% After International Launch Of Mobi Insulin Pump System
Simply Wall St. · Sep 30
Q2 Earnings Highlights: Tandem Diabetes (NASDAQ:TNDM) Vs The Rest Of The Healthcare Technology Stocks
StockStory · Sep 30
Rating changes
Initiated
2026-10-07 · Barclays started covering TNDM at Equal-Weight
Reiterated
2026-09-30 · Citigroup reiterated Neutral on TNDM
Reiterated
2026-09-24 · Truist Securities reiterated Buy on TNDM
Initiated
2026-08-21 · William Blair started covering TNDM at Outperform
Reiterated
2026-08-07 · Citigroup reiterated Neutral on TNDM
Reiterated
2026-08-07 · RBC Capital reiterated Outperform on TNDM

Third-party analyst actions, not SURVYR.'s views. All rating changes

Insider trades
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–

Stats refreshed 2026-10-23 23:42:59 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now

Morning Brief (8 AM ET) & Market Close (4:30 PM ET), weekdays

Indexes, sectors, biggest movers, rates, top news, SURVYR. model changes and what's ahead. Free, two short emails each weekday.

Editions

Free. Not investment advice. Unsubscribe anytime.

SURVYR

Free to use. No card, no ads, no auto-renew.

Systematic research · Not investment advice · Hypothetical unless marked Live · Data: Yahoo Finance (15-min delayed), SEC EDGAR, House Clerk · Important disclosures · Contact desk@coteau.app

How it worksOur promiseTermsPrivacyData statusSend feedback
Coteau 0.9 · Oct 21, 2026